Alev EROĞLU ALTINOVA, Mehmet Muhittin YALÇIN, Özlem TURHAN İYİDİR, Bahar UNCU, Emre ARSLAN, Füsun BALOŞ TÖRÜNER, Ceyla KONCA DEĞERTEKİN

Evaluation of ambulatory arterial stiffness index in hyperthyroidism

Background/aim: Hyperthyroidism causes hemodynamic changes that are associated with adverse cardiovascular outcomes. Twentyfour-hour ambulatory blood pressure monitoring recordings provide us with some essential data: BP variability and ambulatory arterial stiffness index (AASI). In this study, we aimed to investigate AASI and short-term BP variability in both overt and subclinical hyperthyroidism and their relationship with thyroid hormones. Materials and methods: We enrolled 36 patients with subclinical hyperthyroidism, 23 patients with overt hyperthyroidism, and 25 healthy euthyroid controls. ABPM recording was performed for 24 h for all patients. Results: There were no statistically significant differences among the overt hyperthyroidism, subclinical hyperthyroidism, and control groups in terms of AASI (0.43 ± 0.15, 0.38 ± 0.12, 0.42 ± 0.13, respectively; P = 0.315). Variability of diastolic BP was significantly higher in patients with overt hyperthyroidism than in patients with subclinical hyperthyroidism (14.8 ± 2.6 vs. 12.8 ± 2.5%, P = 0.023). There were significant positive correlations between AASI and fT3 (r = 0.246, P = 0.02) and fT4 (r = 0.219, P = 0.04) while TSH was not correlated with AASI (r = 0.023, P = 0.838). After adjusting for confounders, age, 24-h systolic and diastolic BP, variability of systolic and diastolic BP, and fT4 were independent predictors of AASI (r2 = 0.460, P < 0.001). Conclusion: Although AASI did not differ between overt and subclinical hyperthyroidism, there was a positive relationship between AASI and free thyroid hormone levels. Furthermore, short-term BP variability was higher in overt hyperthyroidism than in subclinical hyperthyroidism.

PDF

___

1. Danzi S, Klein I. Thyroid disease and the cardiovascular system. Endocrinol Metab Clin North Am 2014; 43: 517-528.
2. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 2001; 344: 501-509.
3. Klein I, Danzi S. Thyroid disease and the heart. Circulation 2007; 116: 1725-1735.
4. Shargorodsky M, Serov S, Gavish D, Leibovitz E, Harpaz D, Zimlichman R. Long-term thyrotropin-suppressive therapy with levothyroxine impairs small and large artery elasticity and increases left ventricular mass in patients with thyroid carcinoma. Thyroid 2006; 16: 381-386.
5. Gazdag A, Nagy EV, Erdei A, Bodor M, Berta E, Szabo Z, Jenei Z. Aortic stiffness and left ventricular function in patients with differentiated thyroid cancer. J Endocrinol Invest 2015; 38: 133-142.
6. Li Y, Wang JG, Dolan E, Gao PJ, Guo HF, Nawrot T, Stanton AV, Zhu DL, OBrien E, Staessen JA. Ambulatory arterial stiffness index derived from 24-hour ambulatory blood pressure monitoring. Hypertension 2006; 47: 359-364.
7. Kikuya M, Staessen JA, Ohkubo T, Thijs L, Metoki H, Asayama K, Obara T, Inoue R, Li Y, Dolan E et al. Ambulatory arterial stiffness index and 24-hour ambulatory pulse pressure as predictors of mortality in Ohasama, Japan. Stroke 2007; 38: 1161-1166.
8. Dolan E, Thijs L, Li Y, Atkins N, McCormack P, McClory S, OBrien E, Staessen JA, Stanton AV. Ambulatory arterial stiffness index as a predictor of cardiovascular mortality in the Dublin Outcome Study. Hypertension 2006; 47: 365-370.
9. Mancia G, Ferrari A, Gregorini L, Parati G, Pomidossi G, Bertinieri G, Grassi G, di Rienzo M, Pedotti A, Zanchetti A. Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ Res 1983; 53: 96-104.
10. Parati G, Ochoa JE, Lombardi C, Bilo G. Blood pressure variability: assessment, predictive value, and potential as a therapeutic target. Curr Hypertens Rep 2015; 17: 537.
11. Grais IM, Sowers JR. Thyroid and the heart. Am J Med 2014; 127: 691-698.
12. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, StruijkerBoudier H et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27: 2588-2605.
13. Kollias A, Stergiou GS, Dolan E, OBrien E. Ambulatory arterial stiffness index: a systematic review and meta-analysis. Atherosclerosis 2012; 224: 291-301.
14. Palmieri EA, Fazio S, Palmieri V, Lombardi G, Biondi B. Myocardial contractility and total arterial stiffness in patients with overt hyperthyroidism: acute effects of beta1-adrenergic blockade. Eur J Endocrinol 2004; 150: 757-762.
15. Inaba M, Henmi Y, Kumeda Y, Ueda M, Nagata M, Emoto M, Ishikawa T, Ishimura E, Nishizawa Y. Increased stiffness in common carotid artery in hyperthyroid Graves disease patients. Biomed Pharmacother 2002; 56: 241-246.
16. Obuobie K, Smith J, John R, Davies JS, Lazarus JH. The effects of thyrotoxicosis and its treatment on central arterial stiffness. Eur J Endocrinol 2002; 147: 35-40.
17. Czarkowski M, Hilgertner L, Powalowski T, Radomski D. The stiffness of the common carotid artery in patients with Graves disease. Int Angiol 2002; 21: 152-157.
18. Kips JG, Vermeersch SJ, Reymond P, Boutouyrie P, Stergiopulos N, Laurent S, Van Bortel LM, Segers P. Ambulatory arterial stiffness index does not accurately assess arterial stiffness. J Hypertens 2012; 30: 574-580.
19. Delitala AP, Orru M, Filigheddu F, Pilia MG, Delitala G, Ganau A, Saba PS, Decandia F, Scuteri A, Marongiu M et al. Serum free thyroxine levels are positively associated with arterial stiffness in the SardiNIA study. Clin Endocrinol (Oxf) 2015; 82: 592-597.
20. Wu CF, Liu PY, Wu TJ, Hung Y, Yang SP, Lin GM. Therapeutic modification of arterial stiffness: an update and comprehensive review. World J Cardiol 2015; 7: 742-753.
21. Vanderpump MP. The epidemiology of thyroid disease. Br Med Bull 2011; 99: 39-51.
22. di Rienzo M, Grassi G, Pedotti A, Mancia G. Continuous vs intermittent blood pressure measurements in estimating 24- hour average blood pressure. Hypertension 1983; 5: 264-269.
23. Kohno I, Iwasaki H, Okutani M, Mochizuki Y, Sano S, Satoh Y, Ishihara T, Ishii H, Ijiri H, Komori S et al. Circadian blood pressure and heart rate profiles in normotensive patients with mild hyperthyroidism. Chronobiol Int 1998; 15: 337-347.
24. Iglesias P, Acosta M, Sanchez R, Fernandez-Reyes MJ, Mon C, Diez JJ. Ambulatory blood pressure monitoring in patients with hyperthyroidism before and after control of thyroid function. Clin Endocrinol (Oxf) 2005; 63: 66-72.
25. Dorr M, Ittermann T, Aumann N, Obst A, Reffelmann T, Nauck M, Wallaschofski H, Felix SB, Volzke H. Subclinical hyperthyroidism is not associated with progression of cardiac mass and development of left ventricular hypertrophy in middle-aged and older subjects: results from a 5-year followup. Clin Endocrinol (Oxf) 2010; 73: 821-826.